Evidence map›Paper›PMID 34956894›Full record

ArticleFrontiers in oncology2021

Integration of a Geriatric Assessment With Intervention in the Care of Older Adults With Hematologic Malignancies.

Sarah A Wall, Ying Huang, Ashleigh Keiter, Allesia Funderburg, Colin Kloock, Nicholas Yuhasz, Tanya R Gure, Edmund Folefac, Erin Stevens, Carolyn J Presley and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Sarah A WallDivision of Hematology, The Ohio State University, Columbus, OH, United States.
Ying HuangDivision of Hematology, The Ohio State University, Columbus, OH, United States.
Ashleigh KeiterDivision of Hematology, The Ohio State University, Columbus, OH, United States.
Allesia FunderburgThe James Comprehensive Cancer Center, Columbus, OH, United States.
Colin KloockCollege of Medicine, The Ohio State University, Columbus, OH, United States.
Nicholas YuhaszThe James Comprehensive Cancer Center, Columbus, OH, United States.
Tanya R GureDivision of Geriatric Medicine, The Ohio State University, Columbus, OH, United States.
Edmund FolefacThe James Comprehensive Cancer Center, Columbus, OH, United States.
Erin StevensDivision of Palliative Medicine, The Ohio State University, Columbus, OH, United States.
Carolyn J PresleyThe James Comprehensive Cancer Center, Columbus, OH, United States.
Nicole O WilliamsThe James Comprehensive Cancer Center, Columbus, OH, United States.
Jessica L Krok-SchoenCollege of Health Sciences, The Ohio State University, Columbus, OH, United States.
Michelle J NaughtonDivision of Cancer Control and Prevention, The Ohio State University, Columbus, OH, United States.
Ashley E RoskoDivision of Hematology, The Ohio State University, Columbus, OH, United States.
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
OSU as a Network Lead Academic Participating Site for the NCI NCTNUG1CA233331 · NCI · OHIO STATE UNIVERSITY · PI John L. Hays, Dwight H. Owen · 2019 to 2026
$8.9M
NCI NIH HHS P30 CA016058NCI NIH HHS UG1 CA233331
6 · The paper itself

Abstract

The incidence of hematologic malignancies (HMs) is highest in the seventh decade of life and coincides with increasing occult, age-related vulnerabilities. Identification of frailty is useful in prognostication and treatment decision-making for older adults with HMs. This real-world analysis describes 311 older adults with HMs evaluated in a multidisciplinary oncogeriatric clinic. The accumulation of geriatric conditions [1-unit increase, hazards ratio (HR) = 1.13, 95% CI 1.00-1.27, p = 0.04] and frailty assessed by the Rockwood Clinical Frailty Scale (CFS, mild/moderate/severe frailty vs. very fit/well, HR = 2.59, 95% CI 1.41-4.78, p = 0.002) were predictive of worse overall survival. In multivariate analysis, HM type [acute leukemia, HR = 3.84, 95% CI 1.60-9.22, p = 0.003; myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN)/bone marrow failure, HR = 2.65, 95% CI 1.10-6.35, p = 0.03], age (per 5-year increase, HR = 1.46, 95% CI 1.21-1.76, p < 0.001), hemoglobin (per 1 g/dl decrease, HR = 1.21, 95% CI 1.05-1.40, p = 0.009), deficit in activities of daily living (HR = 2.20, 95% CI 1.11-4.34, p = 0.02), and Mini Nutrition Assessment score (at-risk of malnutrition vs. normal, HR = 2.00, 95% CI 1.07-3.73, p = 0.03) were independently associated with risk of death. The most commonly prescribed geriatric interventions were in the domains of audiology (56%) and pharmacy (54%). The Rockwood CFS correlated with prescribed interventions in nutrition (p = 0.01) and physical function (p < 0.001) domains. Geriatric assessment with geriatric intervention can be practically integrated into the routine care of older adults with HMs.

Indexed as

frailtygeriatric assessmentgeriatric oncologyhematologic malignancyoncogeriatrics

Identifiers

PMID34956894
PMCPMC8692664
OpenAlexW4200061775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.